Latest Schedule 13D activist filings

Jorey Chernett, a significant shareholder in Neuronetics, Inc., has formally requested a comprehensive review of strategic alternatives, including a potential sale of the company's TMS business.

Anthony Pompliano and Professional Capital Management have amended their Schedule 13D filing, reporting a combined beneficial ownership of 16.43% in ProCap Financial, Inc. following recent merger and acquisition activities.

Shah Capital Management, a significant shareholder, has announced its intention to vote against Novavax's board nominees and executive compensation, citing value destruction and operational failures.

AI Biotechnology LLC, along with affiliated entities and Len Blavatnik, has reported beneficial ownership of 19.99% of OnKure Therapeutics' Class A Common Stock following a private placement and warrant acquisition.

Robert E. Dixon has updated his Schedule 13D filing to report beneficial ownership of 146,665 shares, representing 7.46% of MacKenzie Realty Capital, Inc.'s outstanding common stock.

Mawson Infrastructure Group announces significant board changes and a cooperation agreement with key shareholders, appointing new directors and executive leadership.

Velibor Krstic has acquired 764,435 warrants in Strata Critical Medical, Inc., representing 8.3% of the outstanding public warrants, citing undervaluation and potential strategic discussions.

Paloma Capital Group LLC and Anna Maria Staples have filed an amended Schedule 13D detailing their beneficial ownership of Paloma Acquisition Corp. I ordinary shares.

RBCH Ltd. is increasing its beneficial ownership limit to 19.99% and plans to exercise pre-funded warrants, while director Viktor Fischer has resigned.

IAC Inc. and Barry Diller have entered into a new voting agreement with MGM Resorts International, impacting voting power and director nominations.

IAC Inc. and Barry Diller have entered into a new voting agreement with MGM Resorts International, impacting voting power and director nominations.

Kopernik Global Investors, LLC, through an amendment to its Schedule 13D filing, has disclosed its beneficial ownership of 14.0% of Northern Dynasty Minerals Ltd. common shares, including shares issuable from convertible notes, and indicated potential future actions regarding its investment.

Agriculture Investment Group Corp. has become the majority shareholder of Moolec Science SA following a 9 million dollar preference share conversion.

CEO Andrew Cavaghan has reduced his annual cash salary to $1 in exchange for a performance-linked grant of over 2.4 million shares with price targets up to $35.

A consortium led by Max Wygod has entered into a definitive agreement to acquire Forian Inc. via a tender offer and subsequent merger at $2.17 per share in cash.

Forian Inc. has entered into a definitive merger agreement with an affiliate of Max Wygod to be acquired in an all-cash transaction valued at $2.17 per share.

The Swenson Group and Air T, Inc. have increased their collective beneficial ownership in Bloomia Holdings, Inc. to 60.1% following a rights offering and debt-to-equity conversion.

The Swenson Group and Air T, Inc. have increased their collective beneficial ownership in Bloomia Holdings, Inc. to 60.1% following a rights offering and debt-to-equity conversion.

WE-INN LLC reports a slight decrease in its beneficial ownership percentage of Innventure, Inc. common stock to 5.85% due to an updated share count.

Innovation Endeavors III LP and Dror Berman have reduced their beneficial ownership in Vicarious Surgical Inc. to below 5% after a series of stock sales.

Luminus Management, LLC and its affiliates have amended their Schedule 13D filing to report a combined beneficial ownership of 43.4% of Battalion Oil Corp.'s common stock, including shares issuable upon conversion of preferred stock.

Biogen Inc. announced its definitive agreement to acquire Apellis Pharmaceuticals, Inc. for $41.00 per share in cash plus a contingent value right (CVR) per share, valuing the company at approximately $41 billion.

Biogen Inc. announced its definitive agreement to acquire Apellis Pharmaceuticals, Inc. for $41.00 per share in cash plus a contingent value right (CVR) per share, valuing the company at approximately $41 billion.

Investor Zhengxu He has acquired a 2.6% stake in Phunware, Inc. through a series of open market purchases totaling 520,000 shares.

Brookfield Corporation and BAM Partners Trust have amended their Schedule 13D filing to disclose a new $1 billion margin loan facility, pledging 65 million Class A shares of Brookfield Asset Management Ltd. as collateral.

Brookfield Corporation and BAM Partners Trust have amended their Schedule 13D filing to disclose a new $1 billion margin loan facility, pledging 65 million Class A shares of Brookfield Asset Management Ltd. as collateral.

Bank of America Corporation and its subsidiary, Banc of America Preferred Funding Corp, have amended their Schedule 13D filing to reflect a reduction in their beneficial ownership of Federated Hermes Premier Municipal Income Fund's preferred shares following a partial redemption.

Bank of America Corporation and its subsidiary, Banc of America Preferred Funding Corp, have amended their Schedule 13D filing to reflect a reduction in their beneficial ownership of Federated Hermes Premier Municipal Income Fund's preferred shares following a partial redemption.

ADW Capital Partners, L.P. has amended its Schedule 13D filing to disclose its beneficial ownership of 10,500,000 shares, representing 14.0% of Compass Diversified Holdings, including call options.

Maewyn Capital Partners LLC, along with affiliated entities, has disclosed a beneficial ownership of 6.7% of FrontView REIT Inc.'s common stock, following an investment agreement and the appointment of Charles Fitzgerald to the board.